Pseudomonas Aeruginosa Treatment

Study design and population The study employed a cross-sectional study design to establish the presence of latent-TB in type 1 DM(T1DM) participants. Study participants were recruited from the 5 pediatric and youth diabetes clinics located in Dar es salaam. In each study site, all children and youth with T1DM were included in our study. Recruitment of participants started from Jan 2021 – December 2021. The population included all children and youth aged 1–25 years inclusive attending pediatric diabetes clinics (These clinics include children and youth up to 26 years of age) located in Dar es Salaam, children whose parents gave consent, children aged 12-<18 years, who gave assent on top of parental consent and youth who gave consent. We excluded children with co-morbidity like sickle cell disease, children under one year (who may not be type 1 diabetes) and those above 25 years. Study setting The study was conducted in five health facilities with specific pediatric diabetes and y

Candida is a group of fungi that exists (usually harmlessly) in areas such as the skin, the mouth, the vagina, and the gastrointestinal tract. Candidiasis is an infection caused by Candida fungus, usually Candida Albicans . Candida infection, also known as a yeast infection, is rarely serious in people with healthy immune systems but can sometimes spread to other parts of the body in immunocompromised people. Symptoms depend on the area of infection. On the skin, an overgrowth may cause a rash, while a vaginal yeast infection can cause itching, burning, and abnormal discharge. An oral yeast infection can cause white patches on the tongue, while an overgrowth of Candida in the gut can cause gastrointestinal complaints such as bloating. This article will discuss symptoms of Candida overgrowth, how to stop Candida overgrowth, the role diet plays in Candidiasis, causes of persistent Candida overgrowth, and how to prevent Candidiasis when immunocompromised.

US Navy, Ryan M. Breeden / Flickr cc Two stroke centers in Canada and the United States saw a significant reduction in monthly hospital presentations and workflow speeds in the first two waves of the COVID-19 pandemic, finds a study published today in Scientific Reports . Researchers at Harvard Medical School and the University of Calgary analyzed changes in stroke rates, hospital systems of care, and treatment times at two comprehensive stroke centers in Boston and Calgary before and during the pandemic (January 2018 to May 2021). The study period was divided into period 1 (pandemic wave 1), period 2 (lull), and period 3 (wave 2). No significant rise in hospital stroke deaths Of the 3,816 patients seen at the Calgary clinic, 69.3% had an ischemic stroke before the pandemic, and 30.7% had one during the pandemic; 80.0% were hospitalized. At the Boston center, 2,400 patients had an ischemic stroke, 66.1% of them prepandemic and 33.9% amid the pandemic; only 1% had the same adm

Rafael Azevedo, a resident of Brazil, is suffering from what he calls "the worst pain in the world," two rare ear diseases known as tympanic plexus neuralgia and intermediate nerve neuralgia. "It's a tremendous pain. And what I have to do is to keep my emotions in balance," Azevedo said through his physical therapist and interpreter, Carlos Santos. Azevedo and his wife, Luana Diniz Tormin, are renting an apartment in Connecticut because Tormin was invited to speak at the United Nations to make a humanitarian request on behalf of her husband during an event focused on rare diseases. Courtesy of Luana Diniz Tormin Luana Diniz Tormin outside the United Nations The U.N. General Assembly had passed a resolution in 2021 on addressing the challenges of people living with rare diseases.  But they also are in Connecticut because the only doctor who they believe can help them, Dr. Daniel Roberts , is on the staff at UConn Health . He wrote the only pape

Mupirocin scientific molecular model, 3D rendering (Adobe Stock 490590070 by Alexey Novikov) Hospital-associated infections are still a serious issue nationwide, but a recent study offers some hope in combatting them. Staphylococcus aureus ( S aureus) and methicillin-resistant Staphylococcus aureus (MRSA) are 2 of the most pervasive infections found in intensive care units (ICUs). In an 18-month trial involving 801,668 adult ICU admissions, researchers found that a nasal antibiotic ointment, mupirocin, effectively prevented S aureus infections in critically ill patients. The results showed an 18% reduction in the risk of S. aureus clinical cultures and a 15% reduction in the risk of methicillin-resistant MRSA. These numbers are promising in the fight against these persistent infections. To learn more about the study, "Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs: A Randomized Clinical Trial&qu

A sore throat is a common symptom of many illnesses, ranging from nonserious to life-threatening. Sore throat is also a sign of the coronavirus disease 2019 (COVID-19), the contagious disease caused by the SARS-CoV-2 virus. While it is rare, it is possible to have COVID-19 with a sore throat as the only symptom. A sore throat might also be the first or one of the earliest symptoms. However, fever is more likely to present first or with a sore throat. Additional early symptoms may include loss of taste and smell. It is also possible to have COVID-19 and not have a sore throat. This article will describe sore throat symptoms in COVID-19, sore throat linked to long COVID-19, non-COVID causes, treatments for a COVID-19 sore throat, and more.  AnnaStills / Getty Images Describing Sore Throat Symptoms in COVID No evidence suggests that a COVID-19 sore throat feels different from a sore throat related to another cause, including the common cold,

In this Article Psoriasis, the autoimmune skin disorder that affects more than eight million Americans nationwide, can be debilitating, especially in moderate to severe cases, but thankfully there are a slew of effective treatment options available. Red light therapy, one treatment that has recently grown in popularity, is a form of phototherapy that's a drug-free treatment used for mild to moderate psoriasis cases. Here, with insight from board-certified dermatologists, you'll find answers on everything you need to know about red light therapy, including how it works and if it could improve your skin health. What Is Red Light Therapy? "Red light therapy is a type of therapy that uses light to have an anti-inflammatory impact on the skin," says Marisa Garshick, M.D., a board-certified dermatologist and clinical assistant professor at Cornell University in Ithaca, NY. "More specifically, red light therapy uses light emitting diodes at a specific wavelength to targ

In this Article While many treatments for psoriasis focus on topical medications, like creams and lotions, or systemic agents such as biologics, laser therapy stands in a class of its own. But laser treatment for psoriasis isn't the same as lasers used for cosmetic purposes like skin resurfacing. Instead, the laser in question, called the excimer laser, is a beam of light that targets areas of skin affected by psoriasis symptoms like plaques. While harnessing the power of a laser for psoriasis can be an effective psoriasis treatment for mild to moderate psoriasis, according to the National Psoriasis Foundation, it's not a great idea for all types of psoriasis—nor is it the right option for all cases. With that, here's what you need to know about excimer laser therapy. Laser Therapy 101 What Is Laser Therapy for Psoriasis? Excimer laser therapy is the use of UVB light to treat psoriasis. "The excimer laser provides UVB light at a 308 nanometer wavelength to a localized